News Listing

John Mattick: Whole genome sequencing is medicine’s Snowy Scheme

John Mattick: Whole genome sequencing is medicine’s Snowy Scheme

Apr 13, 2017 07:03 PM
In this opinion piece in The Australian, Garvan's Executive Director, Professor John Mattick AO FAA says that Australia could be a front runner in precision medicine – but we need to act now.

More…

Science and art collaborate on visualising biological data during Vivid Sydney

Science and art collaborate on visualising biological data during Vivid Sydney

MEDIA RELEASE: Apr 11, 2017 03:32 PM
Garvan, CSIRO’s Data61, and the Charles Perkins Centre at The University of Sydney are joining forces for a series of events held as part of Vivid Sydney, showcasing visualisations that are transforming how life scientists view data and communicate discoveries.

More…

Mapping the genome of prostate cancer uncovers a new world of DNA rearrangements

Mapping the genome of prostate cancer uncovers a new world of DNA rearrangements

MEDIA RELEASE: Apr 11, 2017 12:53 PM
Researchers have ‘mapped’ the entire genome of a prostate tumour, revealing previously undetected levels of DNA rearrangements. The findings, from the Garvan Institute of Medical Research, provide an entirely new lens through which to view prostate cancer – and could one day be used to help characterise an individual’s prostate tumour and reveal previously unrecognised information that could influence clinical treatment.

More…

Garvan Institute marks 200th anniversary of Parkinson’s disease

Garvan Institute marks 200th anniversary of Parkinson’s disease

MEDIA RELEASE: Apr 11, 2017 07:22 AM
Today, World Parkinson’s Day marks 200 years since the disease was first identified by Dr James Parkinson.

More…

 World Parkinson's Day: “Fish with Parkinson’s” uncover a druggable pathway

World Parkinson's Day: “Fish with Parkinson’s” uncover a druggable pathway

MEDIA RELEASE: Apr 11, 2017 05:45 AM
Australian scientists have developed a first-of-its-kind model of Parkinson’s disease in zebrafish. In the model, neurodegeneration occurs through a combination of genetic and environmental factors – just as it does in people.

More…

Garvan and Asan Medical Center sign agreement to advance genomic medicine in cancer

Garvan and Asan Medical Center sign agreement to advance genomic medicine in cancer

Apr 10, 2017 11:47 AM
The Garvan Institute of Medical Research and the Asan Medical Center Cancer Institute in Seoul, South Korea, have signed a Memorandum of Understanding (MOU), formalising a cooperative relationship between the two institutes in the areas of research, clinical trials and education.

More…

“The best tool of its kind in the world”: Patient Archive being used to advance diagnosis of rare diseases in WA

“The best tool of its kind in the world”: Patient Archive being used to advance diagnosis of rare diseases in WA

MEDIA RELEASE: Apr 07, 2017 02:00 AM
Western Australia’s Undiagnosed Diseases Program (UDP) has acquired Patient Archive clinical phenotyping software from the Garvan Institute of Medical Research.

More…

A one-two punch for pancreatic cancer: ‘softening’ tumours before chemo markedly improves survival

A one-two punch for pancreatic cancer: ‘softening’ tumours before chemo markedly improves survival

MEDIA RELEASE: Apr 06, 2017 04:00 AM
Australian scientists have uncovered a promising new approach to treating pancreatic cancer, by targeting the tissue around the tumour to make it ‘softer’ and more responsive to chemotherapy. The findings are published today in Science Translational Medicine.

More…

Garvan and Deakin University join forces to accelerate precision medicine through machine learning

Garvan and Deakin University join forces to accelerate precision medicine through machine learning

MEDIA RELEASE: Mar 28, 2017 04:00 AM
The Garvan Institute of Medical Research and the Centre for Pattern Recognition and Data Analytics (PRaDA) at Deakin University will today launch the Garvan-Deakin Program in Advanced Genomic Investigation (PAGI).

More…

Drug Development Conference 2017: Collaboration is key to faster delivery of new cancer treatments

Drug Development Conference 2017: Collaboration is key to faster delivery of new cancer treatments

Mar 24, 2017 03:09 PM
Worlds collide in the landmark Drug Development Conference 2017 which brings together diverse parties that share one aim: to accelerate the delivery of new cancer drugs to patients.

More…

Garvan breast cancer researcher awarded 10-year Endowed Chair

Garvan breast cancer researcher awarded 10-year Endowed Chair

Mar 23, 2017 03:25 PM
Garvan congratulates Associate Professor Elgene Lim, who is one of two inaugural recipients of the National Breast Cancer Foundation Endowed Chair Program.

More…

Cancer Council NSW funding kickstarts research into colorectal cancer, breast cancer and osteosarcoma

Cancer Council NSW funding kickstarts research into colorectal cancer, breast cancer and osteosarcoma

Mar 02, 2017 12:00 AM
Researchers from Garvan’s Cancer Division were last night awarded five Project Grants from Cancer Council NSW.

More…

Rare Disease Day 2017: With research, possibilities are limitless

Rare Disease Day 2017: With research, possibilities are limitless

Mar 01, 2017 12:00 AM
Rare Disease Day took place on Tuesday – and this year, the focus was firmly on research.

More…

NSW Government funding for Garvan scientists to research new treatments for breast and pancreatic cancer

NSW Government funding for Garvan scientists to research new treatments for breast and pancreatic cancer

Feb 17, 2017 09:55 AM
Three of Garvan’s researchers have been awarded three-year Fellowships from Cancer Institute NSW to explore new ways to target breast and pancreatic cancer.

More…

The ‘other’ pancreatic cancer: uncovering the genomic landscape of an enigmatic rare tumour

The ‘other’ pancreatic cancer: uncovering the genomic landscape of an enigmatic rare tumour

MEDIA RELEASE: Feb 16, 2017 05:00 AM
An Australian-led international research effort has revealed that genetic changes normally linked to breast, colon and ovarian cancers could also drive a rare form of pancreatic cancer.

More…

Innovative regenerative medicine approach could yield new treatments for type 1 diabetes

Innovative regenerative medicine approach could yield new treatments for type 1 diabetes

MEDIA RELEASE: Feb 15, 2017 12:21 PM
Researchers from Garvan and the Victor Chang Institute are set to explore a startling new approach to the treatment of Type 1 diabetes, following the announcement today of substantial funding from the Type 1 Diabetes Clinical Research Network (T1DCRN).

More…

Translational breast cancer research – translated to the public

Translational breast cancer research – translated to the public

MEDIA RELEASE: Feb 14, 2017 12:00 AM
The inaugural Community Breast Cancer Research Update is an important interface between the community and breast cancer researchers.

More…

The Rebecca Wilson Fellowship in Breast Cancer Research launches

The Rebecca Wilson Fellowship in Breast Cancer Research launches

MEDIA RELEASE: Feb 08, 2017 12:34 PM
Congratulations Dr Christine Chaffer, recipient of the Rebecca Wilson Fellowship in Breast Cancer Research.

More…

Diabetes Australia funding to propel new metabolic research at Garvan

Diabetes Australia funding to propel new metabolic research at Garvan

Feb 06, 2017 04:58 PM
Three of Garvan’s scientists have been awarded research grants from Diabetes Australia to support their work in preventing and treating diabetes and related conditions.

More…

 Lions Club Governors see firsthand the power of partnership with Garvan

Lions Club Governors see firsthand the power of partnership with Garvan

Jan 16, 2017 05:15 PM
Governors of Lions Australia have visited Garvan to learn more about the Lions Kids Cancer Genome Project, a $4 million collaborative project that will sequence the genomes of 400 Australian children with high-risk cancer.

More…


© Garvan Institute 2013